Ann Marie Kaukonen

Mesoporous silicon microparticles for oral drug delivery: Loading and release of five model drugs

Jarno Salonen, L. Laitinen, Ann Marie Kaukonen et al. · Journal of Controlled Release · 2005 · 534 citations

Nanoparticles, Nanomedicine, Model Drugs +9

Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products

Leab Sek, Christopher J. H. Porter, Ann Marie Kaukonen et al. · Journal of Pharmacy and Pharmacology · 2002 · 301 citations

Susceptibility to Lipase-Mediated Digestion Reduces the Oral Bioavailability of Danazol After Administration as a Medium-Chain Lipid-Based Microemulsion Formulation

Christopher J. H. Porter, Ann Marie Kaukonen, Ben J. Boyd et al. · Pharmaceutical Research · 2004 · 241 citations

Lipid Preparation, Pharmaceutical Science, Oral Bioavailability +3

Mesoporous silica material TUD-1 as a drug delivery system

T. Heikkilä, Jarno Salonen, Jaani Tuura et al. · International Journal of Pharmaceutics · 2006 · 229 citations

Nano-drug Delivery, Chemistry, Drug Delivery System +1

Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: Studies with halofantrine

Christopher J. H. Porter, Ann Marie Kaukonen, Agnes Taillardat‐Bertschinger et al. · Journal of Pharmaceutical Sciences · 2004 · 215 citations

Lipid Analysis, Lipid Preparation, Pharmaceutical Science +8